US Patent Issued to CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) on Aug. 26 for "FGFR inhibitor compound in solid form and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,138, issued on Aug. 26, was assigned to CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) Co. LTD. (Hebei, China).

"FGFR inhibitor compound in solid form and preparation method therefor" was invented by Zhifei Fu (Shanghai), Miaorong Luo (Shanghai), Jikui Sun (Shanghai), Yang Zhang (Shanghai), Jian Li (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are the solid form, crystalline form, crystal form A of a compound of formula (I), and a preparation method therefor, crystal form B and a preparation method therefor. Also disclosed are use of the solid form, crystalline form, crystal form A, and crystal ...